Skip to content

Advertisement

Translational Respiratory Medicine
Translational Respiratory Medicine Cover Image
  • Research
  • Open Access

Epidemiology of bronchial asthma and asthma control assessment in Henan Province, China

  • 1,
  • 1Email author,
  • 1,
  • 1,
  • 1,
  • 1,
  • 1,
  • 1,
  • 1,
  • 1,
  • 1 and
  • 1
Translational Respiratory Medicine20142:5

https://doi.org/10.1186/2213-0802-2-5

©  Zhang et al.; licensee Springer. 2014

  • Received: 15 November 2013
  • Accepted: 26 February 2014
  • Published:

Abstract

Background

Prevalence of bronchial asthma, asthma treatment assessment, and estimation of the control level among asthma patients in Henan Province, China are reported in this paper.

Methods

We selected 10 among the 109 cities and districts in Henan province using a multistage stratified cluster random sampling method. A total of 500 households from each city and district were chosen. Approximately 20,000 residents from a total of 5,000 households were randomly selected to answer a questionnaire recommended by the China Asthma Alliance. Asthma patients were asked to answer a detailed questionnaire using the symptom-based guidelines to assess the levels of disease control.

Results

The overall prevalence of asthma was 0.73% ± 0.12%. Urban and rural residents had asthma prevalence rates of 1.1% ± 0.23% (88/7,924) and 0.48% ± 0.12% (57/11,792), respectively. Among the asthma patients, only 33.8% (52) received regular medication, 25% (13) used oral glucocorticoids, and 71.1% (37) used oral theophylline. The classified control levels of patients were as follows: 33.1% controlled, 49.7% partially controlled, and 17.2% uncontrolled. A total of 38.5% and 27.5% of regularly and irregularly treated asthma patients reached controlled level, respectively. The two groups significantly differed in asthma control level.

Conclusion

Asthma prevalence is low in Henan Province, China. Urban residents have higher prevalence of asthma than rural residents do. Patients with asthma receive insufficient medication, resulting in suboptimal asthma control. Improvement in diagnosis and treatment of asthma patients is urgently needed.

Keywords

  • Prevalence
  • Socioeconomic status
  • Medications for asthma
  • Asthma control
  • Asthma guideline

Background

Bronchial asthma is a common chronic disease of the respiratory system that affects approximately 300 million people worldwide [1]. Current Global Initiative for Asthma (GINA) guidelines reported that the prevalence of asthma is estimated to be 1% to 18% [2]. Reports have indicated changes in the overall prevalence of asthma [3–5]. However, a firm conclusion on whether the trend is increasing or declining in a particular country for a certain period is not available [6, 7]. As of this writing, few epidemiological data on national asthma prevalence have been reported in China. The Chinese population has relatively low asthma prevalence. Investigation conducted by the National Prevention and Treatment of Children Asthma Group in 2003, which included 430,000 children aged between 0 and 15 years old in 43 cities, reported that the prevalence of childhood asthma in the urban environment is 1.97% [8]. The estimated incidence of asthma was 1.05% in Henan Province in 2000 [9]. Time trends and regional variations in asthma prevalence are difficult to assess in China because of insufficient data [10]. GINA guidelines have been the main reference source for the national asthma guidelines, and the recommended asthma control classification is widely adopted by general practitioners and respiratory specialists in China in the assessment of disease control among asthma patients. We aim to report the prevalence of asthma among residents in Henan Province in 2010 and to evaluate the treatment and disease control among asthma patients. An assessment of the asthma disease, treatment, and control level was also conducted.

Henan province is located at the eastern part of China (31° 23′ N to 36°22′ N, between 110° 21′ E and 116°39′ E). Henan has 19 cities and is a developing province with a population of approximately 104,890,000 in 2012 [11].

Methods

Study sample

This cross-sectional study of randomly selected residents in Henan Province was conducted from June 2010 to January 2011. The sampling unit comprised groups of people living together as families or individuals living alone. The sample size was estimated as follows: overall prevalence was P = 1.05% (α = 0.05) and estimated total sample size was 10,000. The actual completed sample size was 19,878, which included 10,275 (51.7%) males and 9,603 (48.3%) females.

This study used stratified multi-stage cluster random sampling method (Figure 1). Henan Province comprised 109 counties (county level city) and districts. The counties were divided into three groups according to their economic status: high-, middle-, and low-level groups [12]. Districts were divided into two groups according to economic status: high- and low-level groups [12]. Three counties (one county from each group) and two districts (one district from each group) were randomly selected. Two towns were selected in each county, and two streets were selected in each district. Two administrative villages were selected in each township and two communities in each street. Finally, 500 household residents were randomly selected in each administrative village and community. A total of 3,000 households in rural areas and 2,000 households in urban areas were sampled. The sample was weighed to rural areas (2,000 vs. 3,000 subjects) for population in urban areas accounted for 60% of the total in Henan province. Each investigated group comprised field investigators, and survey instructors. Field investigators were trained medical interns and residents. They surveyed each household member using questionnaires. Survey instructors, who were associated chief respiratory physicians and higher-ranking medical practitioners, were responsible for organization, guidance, inspection, and quality control. We adopted the asthma questionnaire recommended by the China Asthma Alliance. The survey included general condition questions, an asthma-screening questionnaire, and a questionnaire for asthma patients. The investigation period was from April 2010 to October 2010.
Figure 1
Figure 1

Sampling flowchart.

Asthma diagnosis

The diagnostic criteria for bronchial asthma [13] used in both questionnaires and lung function tests included the following items. The subject should have been previously diagnosed with asthma. If the subject had no asthma history, the following 10 questions (Qs) were asked: Q1. Have you had recurrent (1) wheezing, (2) coughing, (3) breathlessness, (4) dyspnea, or (5) chest tightness more than three times?; Q2. Do you often have night or morning attacks of the symptoms in Q1?; Q3. Have you ever been awakened at night by these symptoms?; Q4. Have you ever experienced difficulty of breathing or retarded expiratory flow?; Q5. Do you hear wheezing sounds from your chest whenever these symptoms occur?; Q6. Do your symptoms resolve spontaneously?; Q7. Do your symptoms disappear after taking salbutamol or theophylline?; Q8. Do your symptoms occur or worsen during a certain season?; Q9. Do your immediate family members have asthma?; and Q10. Do your symptoms occur during or after exercise? These criteria for asthma are listed in Table 1. For suspected asthma patients, a lung function test was arranged in our hospital to establish a diagnosis. An increase in FEV1 of ≥12% and ≥200 ml after administration of a bronchodilator indicates reversible airflow limitation consistent with asthma.
Table 1

Criteria for asthma in this study

 

Asthma

Suspected asthma

Q1 (1)

Yes

No

Yes

No

Q1 (2)–(5)

 

Yes

 

Yes

Q2–Q10

Yes ≥ 5

Yes ≥ 6

Yes ≥ 3, but < 5

Yes ≥ 4, but < 6

Asthma control

Asthma control was assessed for 4 weeks using the asthma control classification recommended by GINA. Table 2 describes the characteristics of controlled, partially controlled, and uncontrolled asthma.
Table 2

Levels of asthma control

Assessment of current clinical control (preferably over 4 weeks)

Characteristics

Controlled (all of the following)

Partially controlled (any measure present)

Uncontrolled

Daytime symptoms

None (twice a week or less)

More than twice a week

Three or more features of partially controlled asthma

Limitation of activities

None

Any

Nocturnal symptoms

None

Any

Need for relief/rescue treatment

None (twice a week or less)

More than twice a week

Statistical analysis

Prevalence rates with 95% confidence intervals were estimated for all participants in each sample area and for participants in each age group. An Χ2 test was used for prevalence comparison across the two groups. A P value of less than 0.05 was considered statistically significant.

All data analyses were performed using SPSS version 19.0 (SPSS, Inc., Chicago, IL).

Results

Prevalence of asthma

Among the 19,861 participants in this study, 51.7% (10,275) were males. Table 3 summarizes the demographic and health profiles of the sampling areas. Sex did not vary significantly, but education level, smoking habit, and medical insurance of the residents varied between the rural and urban sampling areas. A total of 145 people were diagnosed as asthma sufferers, including 79 males. The total morbidity rate was 0.73% ± 0.12%, and prevalence rates of male and female were 0.76% ± 0.17% and 0.69% ± 0.17%, respectively. Table 4 lists the prevalence rates in each sampling area.
Table 3

Sample characteristics in Henan Province from January 2010 to June 2010

 

Urban

Rural

P-value

 

Zhongyuan district in Zhengzhou (economic level – H)

Longting District in Kaifeng (economic level – L)

Zhongmu county (economic level – H)

High-tech zone in Puyang City (economic level – L)

Mengjin County (economic level – M)

 

Subjects (n)

4,017

3,907

4,180

3,894

3,718

 

Females

48.8%

49.5%

48.1%

48.0%

48.8%

0.686

College degree

4.3%

8.8%

0.9%

1.2%

1.2%

〈0.01

Without medical insurance

0.4%

4.5%

1.1%

0.3%

0.5%

〈0.01

Smoke or smoked in the past

16.2%

21.1%

23.1%

22.5%

21.1%

〈0.01

Table 4

Asthma prevalence in each sampling area in Henan Province from January 2010 to June 2010

Sampling area

No. of samples

Cases of asthma

Prevalence of asthma (%)

P value

Urban area

7,924

88

1.11 ± 0.23

<0.01*

Zhongyuan District in Zhengzhou (economic level – H)

4,017

34

0.846 ± 0.28

 

Longting District in Kaifeng (economic level – L)

3,907

54

1.382 ± 0.37

0.02**

Rural area

11,792

57

0.483 ± 0.12

 

Zhongmu County (economic level – H)

4,180

33

0.789 ± 0 .27

 

High-tech zone in Puyang City (county) (economic level – L)

3,894

6

0.154 ± 0.12

<0.01***

Mengjin County (economic level – M)

3,718

18

0.484 ± 0.22

 

*Comparison of asthma prevalence between residents in urban and rural areas. **Comparison of prevalence in different urban areas. ***Comparison of asthma prevalence among residents in different rural areas.

Prevalence of asthma among urban residents (Longting District of Kaifeng, Zhongyuan District of Zhengzhou) was 1.1% ± 0.23% (88/7,924), whereas that in rural residents (high-tech zone in Puyang, Mengjin County, and Zhongmu County) was 0.48% ± 0.12% (57/11,792). A significant difference was found for prevalence of asthma between rural and urban areas (Χ2 = 25.13, P < 0.01). The prevalence of asthma among urban residents in areas with different economic development levels was significantly different (Χ2 = 5.176, P = 0.02). The prevalence of asthma among rural residents in areas with different economic development levels was significantly different (Χ2 = 16.92, P < 0.01).

Prevalence of asthma in different age groups

The survey, which included 2,857 children, showed that 13 children had asthma. The prevalence of asthma in children was 0.49% ± 0.26%. A total of 17,004 participants were adults aged ≥14 years, among which 131 had asthma. The prevalence of asthma in adults was 0.77% ± 0.13%. No significant difference was observed between the prevalence rate of adults and children (P = 0.10). Table 5 shows the prevalence of asthma in the different age groups.
Table 5

Asthma prevalence in the different age groups

Age group (years)

No. of samples

Asthma cases

Prevalence (%)

P value

Children

    

0–13

2,694

13

4.8 ± 2.6

 

Adults

17,167

131

7.6 ± 1.3

0.10*

14–25

2,982

13

4.3 ± 1.2

 

26–45

6,597

30

4.5 ± 2.3

 

46–65

5,328

49

9.2 ± 2.5

 

66–75

1,541

21

13.6 ± 5.7

 

≥76

719

19

26.4 ± 11.7

 

Total

19,861

145

7.3 ± 1.2

 

*Comparison of prevalence rates between adults and children.

Medications used for treating asthma

Among 154 patients with asthma, only 33.8% (n = 52) received asthma medication regularly. Among patients who received regular treatment, 25% (n = 13) used oral glucocorticoids, 71.1% (n = 37) used oral theophylline, 9.6% (n = 5) used oral leukotriene modifiers, 3.8% (2) used oral short-acting β2 receptor agonist, 5.8% (n = 3) used oral long-acting β2 receptor agonist, 17.3% (n = 9) used glucocorticoid inhalation, 7.7% (n = 4) used long-acting β2 agonist inhalation, 7.7% (n = 4) used short-acting β2 receptor agonist inhalation, 1.9% (n = 1) used intravenous corticosteroids, and 1.9% (n = 1) used intravenous glucocorticoids. Among the 52 people who received regular treatment, 32.7% (n = 17) used a combination of two or more kinds of medicines. The most common combination therapy was oral corticosteroids and oral theophylline (n = 7 cases). Seven cases inhaled corticosteroids, and only two cases used medication combined with inhaled short-acting β2 receptor agonist.

Asthma control

All 145 asthma patients received clinical evaluation of asthma control by symptom-based guidelines. The controlled level was achieved in 48 (33.1%) of the patients. A total of 72 (49.7%) patients achieved partially controlled level, and 25 (17.2%) patients were classified as uncontrolled. Patients receiving regular treatment accounted for 38.5% (n = 20) in the controlled group and 61.5% in the partially controlled and uncontrolled groups. Among patients without regular treatment, 27.5% (n = 28) had controlled asthma and 72.5% had partially controlled and uncontrolled asthma. Patients who received medicines regularly and those who did not showed significant difference in asthma control.Asthma control rate among urban residents living in Zhongyuan District of Zhengzhou and Longting District of Kaifeng City was 0.35 and 0.39, respectively. Asthma control rates among rural residents living in Zhongmu County, high-tech zone in Puyang, and Mengjin County were 0.37, 0.33, and 0.05, respectively (Figure 2). The level of asthma control in Mengjin County was lower compared with that of the other sample areas.
Figure 2
Figure 2

The bars show asthma prevalence, and the curve shows asthma control rate in the sampling areas. Asthma control rate was computed as the ratio of controlled to partially controlled and uncontrolled asthma sufferers.

Table 6 presents the characteristics of asthma sufferers according to the level of control. Among patients with partially controlled and uncontrolled asthma, untreated patients comprised a higher percentage than treated patients did (41.93% vs. 20.77%, p < 0.01). Patients in urban areas showed a higher rate of controlled asthma than those in rural areas (20.78% vs. 10.39%, p < 0.01).
Table 6

Characteristics of asthma sufferers by control classification

 

Medication

Educational status

Age

Area

Smoking history

 

Treated (% asthma)

Untreated (% asthma)

College degree (% asthma)

Without college degree (% asthma)

Child (% asthma)

Adult (% asthma)

Urban (% asthma)

Rural (% asthma)

Never smoked

Smoke or ever smoked

Controlled

20 (13.79%)

28 (18.18%)

1 (0.65%)

47 (30.52%)

2 (1.30%)

11 (7.14%)

32 (20.78%)

16 (10.39%)

34

14

Partially controlled and uncontrolled

32 (20.77%)

65 (41.93%)

8 (5.19%)

89 (57.79%)

46 (29.87%)

86 (55.84%)

56 (36.36%)

41 (26.62%)

44

28

P value

P < 0.01

 

P = 0.02

 

P = 0.132

 

P < 0.01

 

P = 0.01

 

Discussion

This cross-sectional observational study showed that the prevalence rate of asthma in Henan Province, China was 0.73%, whereas a prevalence rate of 1.05% was reported in 2000 by Wang et al. [9]. The prevalence of asthma in other areas in China varied widely, with only 0.38% in Qinghai Province [14] and 0.94% in Guangdong Province [15]. Compared with previous studies, our research focused more on the differences in asthma prevalence between urban and rural areas and prevalence in areas with different economic levels. We determined the relationship between socioeconomic status and asthma prevalence. As reported previously, asthma comprises a range of heterogeneous phenotypes that differ in presentation, etiology, and pathophysiology. The risk factors for each recognized phenotype of asthma are complex and include genetic, environmental, and host factors. In terms of social environment and lifestyle, the increase in the prevalence of asthma was suggested to be related to modern Western culture [16, 17]. Chinese lifestyle is transitioning from traditional to modern more quickly and at a shorter period than in many other countries [18]. Compared with the data (prevalence rate = 1.05%) obtained 10 years ago, the trend in the prevalence of asthma in Henan Province did not increase. This result may be related to the under-developed economy of Henan province. The province has a rural population of nearly 60% [11], and this population retains the traditional lifestyle. The role of outdoor air pollution in causing asthma remains unclear [3]. Previous studies have shown that the prevalence rate of asthma among city residents was 1.1%, which was significantly higher than that in rural areas (0.48%). Outdoor environmental pollution may be the main reason for this phenomenon. A higher concentration of harmful gas and fine particulate matter (PM2.5) is present in outdoor air in cities than in rural areas. PM2.5 is not only associated with increasing asthma prevalence among children with related emergency and hospitalization [19], but also with adult-onset asthma [20].

In this study, we found that the prevalence of asthma in a city with a high-level economy was lower than that in a city with a low-level economy. By contrast, prevalence of asthma in a rural area with a high-level economy was higher than that in a rural area with a low-level economy. Previous studies have indicated that the prevalence of asthma is positively associated with socioeconomic status, and the incidence rate in families is negatively associated with economic condition [21, 22]. However, other studies showed contradictory conclusions [23, 24]. Given that social economic status comprises numerous factors including geographical environment, air pollution, and health habits, determining the relationship between socioeconomic status and asthma incidence is difficult [25, 26].

We studied the asthma control issues in rural and urban areas, including medication used and level of disease control among asthma sufferers in these areas. We found that patients receiving long-term treatment accounted for only 33.8%, and that the most commonly used medications were oral glucocorticoids and theophylline. Only two in 145 patients were treated by inhaled corticosteroids combined with rapid-acting β2 receptor agonists. These results showed that asthma management was poor. Implementation of general practitioners, specialists’ consultation, and patients’ education according to the guideline has been strengthened to improve the diagnosis and treatment of asthma in Henan province.

In this study, we used symptom-based guidelines to assess the disease control level of asthma patients. The patient classifications according to the symptom-based guidelines were as follows: controlled, 33.1%; partially controlled, 49.7%; and uncontrolled, 17.2%. Partially controlled and uncontrolled rates accounted for 66.9%. In Canada, asthma control was administered to ~53% of adults in the age range of 18 years old to 54 years old who reported having this disease; asthma control was assessed using symptom-based guidelines [27]. In eight European countries and in Canada, Australia, and the USA, the rate of uncontrolled asthma was 51%; asthma control was assessed using the Asthma Control Questionnaire [28]. In France, Germany, Italy, Spain, and the UK, the uncontrolled rate was ~50%, and asthma control was assessed with the Asthma Control Test [29]. In Henan Province, insufficient management of asthma may be among the reasons for poor asthma control.

In this study, asthma patients were divided into two groups according to control level (Table 6) to determine the differences between the controlled group and the uncontrolled and partially controlled groups. By comparing age, education level, smoking history, regular treatment, and living area, we found that a higher proportion of urban residents and a larger number of sufferers receive regular treatment in the controlled group than in the partially controlled and uncontrolled groups. This finding indicates that urban residents may have access to better treatments than rural residents, and the disease control rate may be higher in urban areas than in rural areas.

This study has limitations and potential biases. Data are limited to one province of China, and these data may not represent the situation in the other Chinese provinces that are geologically different from Henan. The prevalence may also be underestimated because the diagnoses of some patients may have been based on self-reported data or the criteria for asthma may have been overestimated, leading to false positives and false negatives. However, the prevalence results obtained in this study were consistent with those obtained in another study [9]. Biases also exist in asthma control assessment because three children aged below five years old were included in this study and the asthma control questionnaires were completed by their parents.

Conclusion

The study showed that the prevalence of asthma in Henan Province, China was very low. Prevalence of asthma among urban residents was higher than among rural residents. Differences in asthma prevalence were also observed among urban and rural residents living in areas with different economic development levels. Treatment for asthma was insufficient in both urban and rural areas, resulting in suboptimal asthma control results. Future studies should focus on educating primary care physicians and specialists on the importance of asthma control and implementation of the GINA guidelines.

Consent

Written informed consent was obtained from the patient for the publication of this report and any accompanying images.

Acknowledgements

This work was supported by People’s Hospital of Henan Province, Zhengzhou University.

Declarations

Authors’ Affiliations

(1)
Department of Respiratory and Critical Care Medicine, People’s Hospital of Henan Province, Zhengzhou University, Zhengzhou, Henan Province, China

References

  1. Masoli M, Fabian D, Holt S, Beasley R, Global Initiative for Asthma (GINA) Program: The global burden of asthma: executive summary of the GINA dissemination committee report. Allergy 2004, 59: 469–478. 10.1111/j.1398-9995.2004.00526.xView ArticleGoogle Scholar
  2. Revised 2012 Global Initiative for Asthma: Global strategy for asthma management and prevention http://www.ginaasthma.com
  3. Eder W, Ege MJ, von Mutius E: The asthma epidemic. N Engl J Med 2006, 355: 2226–2235. 10.1056/NEJMra054308View ArticleGoogle Scholar
  4. Anandan C, Nurmatov U, van Schayck OCP, Sheikh A: Is the prevalence of asthma declining? Systemic review of epidemiological studies. Allergy 2010, 65: 152–167. 10.1111/j.1398-9995.2009.02244.xView ArticleGoogle Scholar
  5. Centers for Disease Control and Prevention (CDC): Vtial signs: asthma prevalence, disease characteristics, and self-management eduction – United States, 2001–2009. MMWR 2011, 60(17):547–552.Google Scholar
  6. Anderson HR, Gupta R, Strachan D, Limb E: 50 years of asthma: UK trends from 1955 to 2004. Thorax 2007, 62: 85–90. 10.1136/thx.2006.066407View ArticleGoogle Scholar
  7. Simpson CR, Sheikh A: Trends in the epidemiology of asthma in England: a national study of 333,294 patients. J R Soc Med 2010, 103: 98–106. 10.1258/jrsm.2009.090348View ArticleGoogle Scholar
  8. National Cooperation Group on Childhood Asthma(NCGCA): A national wide survey in China on prevalenceof asthma inurban children. (Article in Chinese). Chin J Pediatr 2003, 41: 123–127.Google Scholar
  9. Wang GB, Peng YL, Du CH, Tang BX, Liu JG, Zhen XA, Wang CH, Xing J, Xu JY, Wang GJ, Jiao XF: Prevalence and epidemilogic characters of asthma in Henan Province (Article in Chinese). Chin J Tuberc Respir Dis 2002, 25: 25–28.Google Scholar
  10. Yangzong Y, Shi Z, Nafstad P, Håheim LL, Luobu O, Bjertness E: The prevalence of childhood asthma in China: a systematic review. BMC Public Health 2012, 12: 860. 10.1186/1471-2458-12-860View ArticleGoogle Scholar
  11. The People’s Goverment of Henan province: Introduction of Henan Province. http://www.henan.gov.cn/hngk/
  12. Wang XD: Research on the economical development of Henan Province of China by PCA (principal components analysis). (Article in Chinese). J Anyang Inst Technol 2012, 11(3)):42–44.Google Scholar
  13. Branch of Chinese Medical Association for Respiratory Diseases (BCMARD): Bronchial asthma therapeutic guidelines (definition, diagnosis, treatment of bronchial asthma). (Article in Chinese). Chin J Tuberc Respir Dis 2008, 31((3):177–185.Google Scholar
  14. Gao F, Yang QJ, Zhang HG: Prevalence and epidemilogic characters of asthma in Qinhai Province (Article in Chinese). Chin J Tuberc Respir Dis 2011, 34(3):165–168.Google Scholar
  15. Tang TQ, Ding Y, Zheng JP, Wang XP, Ma QF, Liang B, Chen SW, Cai DM: Prevalence and epidemilogic characters of asthma in Guangdong Province (Article in Chinese). Chin J Tuberc Respir Dis 2000, 23(12):730–733.Google Scholar
  16. Beasley R, Crane J, Lai CK, Pearce N: Prevalence and etiology of asthma. Allery Clin Immuol 2000, 105: S466-S472. 10.1016/S0091-6749(00)90044-7View ArticleGoogle Scholar
  17. Britton J: Parasite, allergy, and asthma. Am J Respir Crit Care Med 2003, 168: 266–267. 10.1164/rccm.2305011View ArticleGoogle Scholar
  18. Yang G, Kong L, Zhao W, Wan X, Zhai Y, Chen C, Koplan JP: Emergence of chronic non-communicable diseases in China. Lancet 2008, 372: 1697–1705. 10.1016/S0140-6736(08)61366-5View ArticleGoogle Scholar
  19. American Thorax Society: What constitutes an adverse health effect of air pollution? Offical statement of the American thorax society. Am J Respir Crit Care Med 2000, 161(2pt 1):665–673.Google Scholar
  20. Künzli N, Bridevaux PO, Liu LJ, Garcia-Esteban R, Schindler C, Gerbase MW, Sunyer J, Keidel D, Rochat T: Swiss cohort study on Air pollution and lung diseases in adults:traffic-related air pollution correlates with adult-onset asthma among never-smokers. Thorax 2009, 64: 664–670. 10.1136/thx.2008.110031View ArticleGoogle Scholar
  21. Farfel A, Tirosh A, Derazne E, Garty BZ, Afek A: Association between socioeconomic status and the prevalence of asthma. Ann Allergy Asthma Immunol 2010, 104(6):490–495. 10.1016/j.anai.2010.03.019View ArticleGoogle Scholar
  22. Kozyrskyj AL, Kendall GE, Jacoby P, Sly PD, Zubrick SR: Association between socioeconomic status and the development of asthma: analyses of income trajectories. Am J Public Health 2010, 100(3):540–546. 10.2105/AJPH.2008.150771View ArticleGoogle Scholar
  23. Ellison-Loschmann L, Sunyer J, Plana E, Pearce N, Zock JP, Jarvis D, Janson C, Antó JM, Kogevinas M: European community respiratory health survey:socioeconomic status, asthma and chronic bronchitis in a large community-based study. Eur Respir J 2007, 29(5):897–905. 10.1183/09031936.00101606View ArticleGoogle Scholar
  24. Almqvist C, Pershagen G, Wickman M: Low socioeconomic status as a risk factor for asthma, rhinitis and sensitization at 4 years in a birth cohort. Clin Exp Allergy 2005, 35(5):612–618. 10.1111/j.1365-2222.2005.02243.xView ArticleGoogle Scholar
  25. Wright RJ, Subramanian SV: Advancing a multilevel framework for epidemiologic research on asthma disparities. Chest 2007, 132(5 Suppl):757S-769S.View ArticleGoogle Scholar
  26. Hancox RJ, Milne BJ, Taylor DR, Greene JM, Cowan JO, Flannery EM, Herbison GP, McLachlan CR, Poulton R, Sears MR: Relationship between socioeconomic status and asthma: a longitudinal cohort study. Thorax 2004, 59(5):376–380. 10.1136/thx.2003.010363View ArticleGoogle Scholar
  27. FitzGerald JM, Boulet LP, McIvor RA, Zimmerman S, Chapman KR: Asthma control in Canada remains suboptimal: The Reality of Asthma Control (TRAC) study. Can Respir J 2006, 13: 253–259.Google Scholar
  28. Partridge MR, van der Molen T, Myrseth SE, Busse WW: Attitudes and actions of asthma patients on regular maintence therapy: The INPIRE study. BMC Pulm Med 2006, 6: 13. 10.1186/1471-2466-6-13View ArticleGoogle Scholar
  29. Demoly P, Paggiaro P, Plaza V, Bolge SC, Kannan H, Sohier B, Adamek L: Prevalence of asthma control among adults in France, Germany, Italy, Spain and the UK. Eur Respir Rev 2009, 18(112):105–112. 10.1183/09059180.00001209View ArticleGoogle Scholar

Copyright

© Zhang et al.; licensee Springer. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.

Advertisement